Cited by 293Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

Ueng, K·2003·European Heart Journal

DOI 10.1016/j.ehj.2003.08.014

Open this paper in CoChat — free account

Abstract

AIMS: This study aimed to assess whether enalapril could improve cardioversion outcome and facilitate sinus rhythm maintenance after conversion of chronic atrial fibrillation (AF). METHODS AND RESULTS: Patients with chronic AF for more than 3 months were assigned to receive either amiodarone (200mg orally 3 times a day; group I: n=75) or the same dosage of amiodarone plus enalapril (10mg twice a day; group II: n=70) 4 weeks before scheduled external cardioversion. The end-point was the time to first recurrence of AF. In 125 patients (86.2%), AF was converted to sinus rhythm. Group II had a trend to a trend to a lower rate of immediate recurrence of AF than group I did (4.3% vs 14.7%, P=0.067). Kaplan-Meier analysis demonstrated a higher probability of group II remaining in sinus rhythm at 4 weeks (84.3% vs 61.3%, P=0.002) and at the median follow-up period of 270 days (74.3% vs 57.3%, P=0.021) than in group II. CONCLUSIONS: The addition of enalapril to amiodarone decreased the rate of immediate and subacute arrhythmia recurrences and facilitated subsequent long-term maintenance of sinus rhythm after cardioversion of persistent AF.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ehj.2003.08.014

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.
Haïssaguerre, M., Jaïs, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., Garrigue, S., Mouroux, A. L., Métayer, P. L., & Clémenty, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391003 · Cited by 8,040
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Atrial Fibrillation Begets Atrial Fibrillation
WIJFFELS, M. C. E. F., Kirchhof, C. J. H. J., Dorland, R., & Allessie, M. A. (1995) · Circulation · doi:10.1161/01.cir.92.7.1954 · Cited by 3,500
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
Gelder, I. C. V., Hagens, V. E., Bosker, H. A., Kingma, J. H., Otto Kamp, B., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,355
Initiation of Atrial Fibrillation by Ectopic Beats Originating From the Pulmonary Veins
Chen, S., HSIEH, M., TAI, C., Tsai, C.-F., Prakash, V. S., Yu, W., Hsu, T., Ding, Y.-A., & Chang, M.-S. (1999) · Circulation · doi:10.1161/01.cir.100.18.1879 · Cited by 1,442
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)
Furberg, C. D., Psaty, B. M., Manolio, T. A., Gardin, J. M., Smith, V. E., & Rautaharju, P. M. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90363-8 · Cited by 1,096
Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing–Induced Congestive Heart Failure
Li, D., Shinagawa, K., Pang, L., Leung, T. K., Cardin, S., Wang, Z., & Nattel, S. (2001) · Circulation · doi:10.1161/hc4601.099402 · Cited by 702
Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized Study
Madrid, A. H., Bueno, M. G., Rebollo, J. M. G., Marín, I., Peña, G., Bernal, E., Rodriguez, A., Cano, L., Cano, J. M., Cabeza, P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000022665.18619.83 · Cited by 685
Electrical reversion of cardiac arrhythmias.
Lown, B. (1967) · Heart · doi:10.1136/hrt.29.4.469 · Cited by 664

Flagged first, then by citations

Show all 45 references

1 of the 45 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Furberg CD, Pasty BM, Manolio TA et al. Prevalence of atrial fibrillation in elderly subjects. Am J Cardiol 1994;74:236-41.
Ewy G, Ulfers L, Hager WD et al. Response of atrial fibrillation to therapy: role of etiology and left atrial diameter. J Electrocardiol 1980;13:119-24.

Sorted by citations

Items 101–200 of 293

Atrial fibrillation and inflammation
Özaydın, M. (2010) · World Journal of Cardiology · doi:10.4330/wjc.v2.i8.243 · Cited by 29
Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion
Tveit, A., Seljeflot, I., Grundvold, I., Abdelnoor, M., Arnesen, H., & Smith, P. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.10.028 · Cited by 28
Systematic Review and Meta-Analysis: Renin-Angiotensin System Inhibitors in the Prevention of Atrial Fibrillation Recurrences. An Unfulfilled Hope
Disertori, M., Barlera, S., Staszewsky, L. I., Latini, R., Quintarelli, S., & Franzosi, M. G. (2011) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-011-6346-0 · Cited by 28
Upstream therapy of atrial fibrillation
Smit, M. D., & Gelder, I. C. V. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.59 · Cited by 27
Mechanisms With Clinical Implications for Atrial Fibrillation–Associated Remodeling: Cathepsin K Expression, Regulation, and Therapeutic Target and Biomarker
Fujita, M., Cheng, X. W., Inden, Y., Shimano, M., Yoshida, N., Inoue, A., Yamamoto, T., Takeshita, K., Kyo, S., Taguchi, N., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000503 · Cited by 27
Non‐Antiarrhythmic Drugs in Atrial Fibrillation: A Review of Non‐Antiarrhythmic Agents in Prevention of Atrial Fibrillation
LALLY, J. A., Gnall, E., Seltzer, J. H., & Kowey, P. R. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00874.x · Cited by 27
Antiarrhythmic potential of aldosterone antagonists in atrial fibrillation
Dąbrowski, R., & Szwed, H. (2012) · Cardiology Journal · doi:10.5603/cj.2012.0043 · Cited by 26
Angiotensin Receptor Blockers and Statins Could Alleviate Atrial Fibrosis via Regulating Platelet-Derived Growth Factor/Rac1 /Nuclear Factor-Kappa B Axis
Yang, D., Yuan, J., Liu, G., Ling, Z., Zeng, H., Chen, Y., Zhang, Y., She, Q., & Zhou, X. P. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.5931 · Cited by 26
Antiarrhythmic Drug Therapy for Atrial Fibrillation: Focus on Atrial Selectivity and Safety
Li, D., Sun, H., & Lévesque, P. (2009) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152509787047621 · Cited by 26
New antiarrhythmic treatment of atrial fibrillation
Naccarelli, G. V., Wolbrette, D. L., Samii, S. M., Banchs, J. E., Penny-Peterson, E., & Gonzalez, M. D. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.4.707 · Cited by 26
Upstream therapies to prevent atrial fibrillation
Dorian, P., & Singh, B. N. (2008) · European Heart Journal Supplements · doi:10.1093/eurheartj/sun033 · Cited by 26
Errors and pitfalls in the non-invasive management of atrial fibrillation
Korantzopoulos, P. G., Kolettis, T. M., Goudevenos, J. A., & Siogas, K. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.11.014 · Cited by 25
Blood Pressure and Atrial Fibrillation: A Combined AF‐CHF and AFFIRM Analysis
Tremblay‐Gravel, M., White, M., Roy, D., Leduc, H., Wyse, D. G., Cadrin‐Tourigny, J., Shohoudi, A., Macle, L., Dubuc, M., Andrade, J. G., et al. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12652 · Cited by 24
Atrial Fibrillation Underlies Cardiomyocyte Senescence and Contributes to Deleterious Atrial Remodeling during Disease Progression
Adili, A., Zhu, X., Cao, H., Tang, X., Wang, Y., Wang, J., Shi, J., Zhou, Q., & Wang, D. (2022) · Aging and Disease · doi:10.14336/ad.2021.0619 · Cited by 24
Management of Atrial Fibrillation: Translating Clinical Trial Data into Clinical Practice
Eagle, K. A., Cannom, D. S., & Garcia, D. A. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.05.016 · Cited by 24
Influence of diabetes on the maintenance of sinus rhythm after a successful direct current cardioversion in patients with atrial fibrillation
Soran, H., Younis, N., Currie, P., Silas, J. H., Jones, I. R., & Gill, G. (2008) · QJM · doi:10.1093/qjmed/hcm123 · Cited by 24
Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?
Choudhury, A., Varughese, G. I., & Lip, G. Y. H. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.13.2193 · Cited by 23
Fibrillatory rate response to candesartan in persistent atrial fibrillation
Bollmann, A., Tveit, A., Husser, D., Stridh, M., Sörnmo, L., Smith, P., & Olsson, S. B. (2008) · EP Europace · doi:10.1093/europace/eun195 · Cited by 23
Prevention of Recurrent Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers: A Systematic Review and Meta-Analysis of Randomized Trials
Bhuriya, R., Singh, M., Sethi, A., Molnár, J., Bahekar, A., Singh, P. P., Khosla, S., & Arora, R. R. (2011) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248410389045 · Cited by 22
Lifestyle changes in atrial fibrillation management and intervention
Yang, L., & Chung, M. K. (2023) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15803 · Cited by 22
Angiotensin II induces complex fractionated electrogram in a cultured atrial myocyte monolayer mediated by calcium and sodium-calcium exchanger
Tsai, C., Chiang, F., Chen, W., Hwang, J., Tseng, C.-D., Wu, C., Yu, C., Wang, Y., Lai, L., & Lin, J.-L. (2010) · Cell Calcium · doi:10.1016/j.ceca.2010.10.005 · Cited by 22
Defining “Culprit Mechanisms” in Arrhythmogenic Cardiac Remodeling
Nattel, S. (2004) · Circulation Research · doi:10.1161/01.res.0000133229.19586.bb · Cited by 22
Combination Therapy With Amiodarone and Enalapril in Patients With Paroxysmal Atrial Fibrillation Prevents the Development of Structural Atrial Remodeling
Komatsu, T., Ozawa, M., Tachibana, H., Satō, Y., Orii, M., Kunugida, F., & Nakamura, M. (2008) · International Heart Journal · doi:10.1536/ihj.49.435 · Cited by 22
EURASIAN CLINICAL RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF ATRIAL FIBRILLATION
Sp, G., Панченко, Е. П., Станиславовна, К. Е., Laiovich, L. I., Maykov, E. B., Mironov, N. Y., & Shakhmatova, O. O. (2019) · Eurasian heart journal · doi:10.38109/2225-1685-2019-4-4-85 · Cited by 21
Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation—indications and contraindications
Lévy, S. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0480 · Cited by 20
Angiotensin II Type 1 Receptor Inhibition is Associated with Reduced Tachyarrhythmia-Induced Ventricular Interstitial Fibrosis in a Goat Atrial Fibrillation Model
Chrysostomakis, S. I., Karalis, I. K., SIMANTIRAKIS, E. N., Koutsopoulos, A. V., Mavrakis, H. E., CHLOUVERAKIS, G. I., & Vardas, P. E. (2007) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-007-6053-z · Cited by 19
Clinical trials, the renin angiotensin system and atrial fibrillation
Birnie, D. H., Gollob, M. H., & Healey, J. S. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000231408.69307.9b · Cited by 18
Renin-angiotensin system inhibitors for prevention of recurrent atrial fibrillation: a meta-analysis
Li, T., Zang, W., Chen, Y.-L., Geng, N., Ma, S., & Li, X. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12063 · Cited by 18
Simplified cardioversion service with intravenous midazolam
Hubner, P. J. B. (2004) · Heart · doi:10.1136/hrt.2003.033050 · Cited by 18
Understanding and Managing Atrial Fibrillation in Patients with Kidney Disease.
Khouri, Y. S., Stephens, T., Ayuba, G. A., Al‐Ameri, H., Juratli, N., & McCullough, P. A. (2015) · Europe PMC (PubMed Central) · doi:10.4022/jafib.1069 · Cited by 18
Comparison of Atorvastatin and Simvastatin in Prevention of Atrial Fibrillation After Successful Cardioversion
Naji, F. H., Šuran, D., Kanič, V., Vokač, D., & Šabović, M. (2009) · International Heart Journal · doi:10.1536/ihj.50.153 · Cited by 18
Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation
Climent, V. E., Marín, F. R., Mainar, L., Roldán, V., Garcı́a, A., Martı́nez, J. G., & Lip, G. Y. H. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.11.044 · Cited by 17
Increased Expression of Mineralocorticoid Receptor and 11β‐Hydroxysteroid Dehydrogenase Type 2 in Human Atria During Atrial Fibrillation
De‐An, P., Li, L., Xu, Z., Jin‐Yu, H., Zheng-Ming, X., Wang, M., Qiang, Y., & Shi‐eng, H. (2010) · Clinical Cardiology · doi:10.1002/clc.20689 · Cited by 16
Review: Atrial fibrillation and renin-angiotensin system
Serra, J. L. P., & Bendersky, M. (2008) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944708092111 · Cited by 16
Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation
Lip, G. Y. H., Frison, L., & Grind, M. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01780.x · Cited by 17
Association of pretreatment with angiotensin-converting enzyme inhibitors with improvement in ablation outcome in atrial fibrillation patients with low left ventricular ejection fraction
Mohanty, S., Mohanty, P. K., Trivedi, C. G., Gianni, C., Bai, R., BURKHARDT, J. D., Gallinghouse, J. G., Horton, R., Sánchez, J., Hranitzky, P. M., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.06.007 · Cited by 15
Inhibition of the Renin-Angiotensin System for Prevention of Atrial Fibrillation
Zografos, T. A., & Katritsis, D. G. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02832.x · Cited by 15
Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on the Long-Term Outcome after Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation
Klemm, H. U., Heitzer, T. A., Ruprecht, U., Meinertz, T., & Ventura, R. (2010) · Cardiology · doi:10.1159/000318016 · Cited by 15
A paradigm shift in treatment for atrial fibrillation: from electrical to structural therapy?
Heidbüchel, H. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.06.008 · Cited by 15
Non-Antiarrhythmic Drugs to Prevent Atrial Fibrillation
Moro, C., Hernández‐Madrid, A., & Matía, R. (2010) · American Journal of Cardiovascular Drugs · doi:10.2165/11537270-000000000-00000 · Cited by 15
Signal-averaged P wave duration and the long-term risk of permanent atrial fibrillation
Dixen, U., Larsen, M. V., Ravn, L. S., Parner, J., & Jensen, G. B. (2008) · Scandinavian Cardiovascular Journal · doi:10.1080/14017430701652282 · Cited by 14
Renin‐Angiotensin System Blocker Use May Be Associated with Suppression of Atrial Fibrillation Recurrence after Pulmonary Vein Isolation
Ishikawa, K., Yamada, T., Yoshida, Y., Takigawa, M., Aoyama, Y., Inoue, N., Tatematsu, Y., Nanasato, M., Kato, K., Tsuboi, N., et al. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02949.x · Cited by 14
Atrial Fibrillation and Hypertension: “Quo Vadis”
Kwon, Y., Walker, M., Patel, P., Kwon, O., Koene, R. J., & Duprez, D. A. (2022) · Current Hypertension Reviews · doi:10.2174/1573402118666220112122403 · Cited by 15
Angiotensin II inhibition and prevention of atrial fibrillation and stroke**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
Bourassa, M. G. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.008 · Cited by 14
Management of patients with arterial hypertension and atrial fibrillation
Chazova, I. E., Голицын, С. П., Zhernakova, Y. V., Zheleznova, E. A., Станиславовна, К. Е., Миронов, Н. Ю., Kostyukevich, M. V., Laiovich, L. I., Utsumueva, M. D., Александровна, Ю. Ю., et al. (2021) · Systemic Hypertension · doi:10.26442/2075082x.2021.3.201077 · Cited by 13
Comparison of the effects of quinapril and irbesartan on P-wave dispersion in hypertensive patients
Güntekin, Ü., Güneş, Y., Tuncer, M., Şimşek, H., & Güneş, A. K. (2008) · Advances in Therapy · doi:10.1007/s12325-008-0083-1 · Cited by 12
Upstream Effect for Atrial Fibrillation: Still a Dilemma?
Calò, L., Martino, A., Sciarra, L., Ciccaglioni, A., Ruvo, E. D., Luca, L. D., Sette, A., Giunta, G., Lioy, E., & Fedele, F. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02942.x · Cited by 13
Relationship between −344T/C polymorphism in the aldosterone synthase gene and atrial fibrillation in patients with essential hypertension
Sun, X., Yang, J., Hou, X., Li, J., Shi, Y., & Jing, Y. (2011) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320311417654 · Cited by 13
Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study)
Yamabe, H., Kaikita, K., Matsumura, T., Iwasa, A., Koyama, J., Uemura, T., Morikami, Y., Tsunoda, R., Morihisa, K., Fujimoto, K., et al. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.07.010 · Cited by 12
The Role of Inflammation in Atrial Fibrillation: A Myth or a Fact?
Toutouzas, K. P., Drakopoulou, M. I., Stefanadi, E., Tousoulis, D. M., Synetos, A. G., Stefanadis, C., Lerakis, S., & Lerakis, S. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181b271a9 · Cited by 12
Upregulation of SERCA2a following short-term ACE inhibition (by enalaprilat) alters contractile performance and arrhythmogenicity of healthy myocardium in rat
Máťuš, M., Kucerova, D., Kružliak, P., Adameová, A., Dóka, G., Turcekova, K., Kmecova, J., Kyselovič, J., Křenek, P., Kirchhefer, U., et al. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2350-1 · Cited by 11
Atrial Fibrillation and Flutter
Brady, P. A., & Gersh, B. J. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_95 · Cited by 12
The Effects of Rate and Rhythm Control on Blood Pressure and Antihypertensive Drug Usage in Patients with Atrial Fibrillation and Hypertension Enrolled in the AFFIRM Trial
MASOOD, S. O., Wasmund, S. L., AKOUM, N. W., Egger, M. J., Hsiai, T. K., & Hamdan, M. H. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01792.x · Cited by 10
Trends in the use of electrical cardioversion for atrial fibrillation: influence of major trials and guidelines on clinical practice
and REVERCAT study investigators, Alegret, J. M., Viñolas, X., Romero‐Menor, C., Pons, S., Villuendas, R., Calvo, N., Pérez‐Rodon, J., & Sabaté, X. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-42 · Cited by 11
Atrial remodeling in persistent atrial fibrillation: the potential role of aldosterone
Korantzopoulos, P. G. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.12.033 · Cited by 11
Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction
Arslan, A., Özaydın, M., Aksoy, F., Arslan, B., Baş, H. A., Erdoğan, D., Varol, E., & Doğan, A. (2016) · Medicina · doi:10.1016/j.medici.2016.02.006 · Cited by 10
Effects of angiotensin-converting enzyme inhibitors beyond lowering blood pressure – are they important for doctors?
Holecki, M. T., Szewieczek, J., & Chudek, J. T. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70586-2 · Cited by 10
Increased Plasma Aldosterone during Atrial Fibrillation Declines following Cardioversion
Soeby-Land, C., Dixen, U., Therkelsen, S., & Kjær, A. (2011) · Cardiology · doi:10.1159/000328462 · Cited by 10
Atrial Fibrillation: Pharmacological Therapy
Patel, C., Salahuddin, M., Jones, A., Patel, A., Yan, G., & Kowey, P. R. (2011) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2011.01.001 · Cited by 10
Evolución a largo plazo de la prescripción de fármacos en pacientes hospitalizados por insuficiencia cardíaca congestiva. Influencia del patrón de disfunción
Shamagian, L. G., Roman, A. V., Lamela, A. V., Veloso, P. R., García‐Acuña, J. M., & González‐Juanatey, J. R. (2005) · Revista Española de Cardiología · doi:10.1157/13073895 · Cited by 10
Drug Therapy for Atrial Fibrillation
Musco, S., Conway, E. L., & Kowey, P. R. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.08.002 · Cited by 10
Atrial Fibrillation and the Renin-Angiotensin-Aldosterone System
Perlini, S., Belluzzi, F., Salinaro, F., & Musc, F. (2013) · InTech eBooks · doi:10.5772/53917 · Cited by 9
Angiotensin II receptor type 1 is upregulated in atrial tissue of patients with rheumatic valvular disease with atrial fibrillation
Cong, H., Li, X., Ma, L., Jiang, H., Mao, Y., & Xu, M. (2010) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2009.10.035 · Cited by 7
Evolution of Left Atrial Systolic and Diastolic Functions in Different Stages of Hypertension: Distinct Effects of Blood Pressure Control
Tsai, C., Hwang, J., Shih, Y.-C., Chiang, F., Lai, L., & Lin, J.-L. (2007) · Cardiology · doi:10.1159/000106680 · Cited by 9
Rendimiento terapéutico de un protocolo prospectivo de cardioversión en la fibrilación auricular persistente
Martínez-Brotons, Á. M., Ruiz‐Granell, R., Morell, S., Plancha, E., Ferrero, Á., Roselló, A. M., Llácer, Á., & García–Civera, R. (2006) · Revista Española de Cardiología · doi:10.1157/13093981 · Cited by 9
Mineralocorticoid receptor, CYP11B2 mRNA expression, and atrial matrix remodelling in patients with atrial fibrillation
Pei, D.-A., Yan, Y.-Y., Li, L., Xu, Z., Huang, J., Wang, M., Xu, Z., Yao, Q., Huang, S.-E., Huang, Q., et al. (2010) · Acta cardiologica. Supplementum · doi:10.1080/ac.65.5.2056239 · Cited by 8
Atrial fibrillation and arterial hypertension
Баранова, Е. И. (2011) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2011--4- · Cited by 9
Drug Therapy for Atrial Fibrillation: What Will Its Role Be in the Era of Increasing Use of Catheter Ablation?
Morrow, J., & Reiffel, J. A. (2008) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02184.x · Cited by 9
Adjuvant Therapy for Atrial Fibrillation
Mohammed, K., Kowey, P. R., & Musco, S. (2009) · Future Cardiology · doi:10.2217/fca.09.57 · Cited by 8
Association of the angiotensinogen M235T polymorphism with recurrence after catheter ablation of acquired atrial fibrillation
Wang, Q., Hu, X., Li, S., Wang, X., Wang, J., Zhang, R., Sun, J., Zhang, P., Feng, X., & Li, Y. (2015) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320315594315 · Cited by 8
Drug Therapy for Atrial Fibrillation
Conway, E. L., Musco, S., & Kowey, P. R. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2008.10.003 · Cited by 8
Pharmacotherapy of Atrial Fibrillation: A Pathophysiological Perspective and Review
Jacob, S., Ali, O. A., Pidlaoan, V., Badheka, A. O., & Kerin, N. Z. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181eea7c5 · Cited by 8
Upstream Therapy for Atrial Fibrillation in Heart Failure
Goette, A. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.07.010 · Cited by 8
Risk factor modification for the primary and secondary prevention of atrial fibrillation. Part 1
Mujović, N. M., Marinković, M. M., Mihajlovic, M., Mujović, N., & Potpara, T. (2020) · Kardiologia Polska · doi:10.33963/kp.15221 · Cited by 9
ARBs, ACE‐Is, or Statins After Catheter Ablation of Atrial Fibrillation?
Deneke, T. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00917.x · Cited by 8
Upstream therapies after pulmonary vein ablation: five negative studies--what's next?
Savelieva, I., & Camm, A. J. (2010) · EP Europace · doi:10.1093/europace/euq402 · Cited by 8
Eurasian clinical guidelines for the diagnosis and treatment of atrial fibrillation in adult patients (2025)
Sp, G., Панченко, Е. П., Mironov, N. Y., Михайловна, Б. М., Gagloeva, D. A., Elfimova, E. M., Станиславовна, К. Е., Laiovich, L. I., Litvin, A. Y., Maykov, E. B., et al. (2025) · Eurasian heart journal · doi:10.38109/2225-1685-2025-3-6-77 · Cited by 8
Evaluation of the Efficacy of Sacubitril/Valsartan on Radiofrequency Ablation in Patients with Hypertension and Persistent Atrial Fibrillation
Zang, X., Zhao, Z., Chen, K., Song, W., Ma, J., Zhou, Y., Liang, E., Fu, H., Wang, X., Zhao, Y., et al. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07493-6 · Cited by 7
Modifiable Risk Factors and Atrial Fibrillation: the Quest for a Personalized Approach
Matei, L.-L., Silişte, C., & Vinereanu, D. (2021) · MAEDICA – a Journal of Clinical Medicine · doi:10.26574/maedica.2020.16.1.88 · Cited by 8
Upstream Therapy for Atrial Fibrillation
Kumagai, K. (2007) · Circulation Journal · doi:10.1253/circj.71.a75 · Cited by 7
The effect of pretreatment with renin-angiotensin-aldosterone system blockers on cardioversion success and acute recurrence of atrial fibrillation
Doğan, A., Akçay, S., Karabacak, M., Türker, Y., Özaydın, M., & Erdoğan, D. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.01997.x · Cited by 7
Reviewing the future of renin-angiotensin system blockade: The role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation
Ducharme, A., & Schiffrin, E. L. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)71170-3 · Cited by 7
Focus on renin–angiotensin system modulation and atrial fibrillation control after GISSI AF results
Durin, O., Pedrinazzi, C., & Inama, G. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32833cdd6f · Cited by 7
Atrial fibrillation and atrial cardiomyopathy—two sides of the same coin?
Pedersen, O. D., Køber, L., & Torp-Pedersen, C. T. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.01.015 · Cited by 7
Right atrial overdrive pacing for prevention of symptomatic refractory atrial fibrillation
Hemels, M. E. W. (2006) · EP Europace · doi:10.1093/europace/euj004 · Cited by 7
Effect of Sacubitril-Valsartan on Restoration and Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation
Chen, Q., Chen, Y., Qin, F., Du, H., Gan, C., Zhou, B., Wang, N., Xiao, M., Ou, Z., Zhao, W., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.870203 · Cited by 6
During ablation for atrial fibrillation, is simultaneous renal artery ablation appropriate?
Hogarth, A. J., Dobson, L. E., & Tayebjee, M. H. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.75 · Cited by 5
Pathophysiology of atrial fibrillation: Insights into the renin–angiotensin system
Heuzey, J. L., Marijon, É., Chachoua, K., Waintraub, X., Lepillier, A., Otmani, A., Lavergne, T., & Pornin, M. (2008) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2008.09.015 · Cited by 6
Prevención de la fibrilación auricular en el paciente hipertenso
Alonso, V. B., von Wichmann, M. D. L. F., & Payeras, A. C. (2007) · Medicina Clínica · doi:10.1157/13098021 · Cited by 6
Perindopril and prevention of atrial fibrillation
Tardif, J., & Talajic, M. R. (2007) · European Heart Journal Supplements · doi:10.1093/eurheartj/sum035 · Cited by 6
Understanding Atrial Fibrillation: The Signal Processing Contribution, Part I
Mainardi, L. T., Sörnmo, L., & Cerutti, S. (2008) · Synthesis lectures on biomedical engineering · doi:10.2200/s00152ed1v01y200809bme024 · Cited by 5
Risk factors modification in atrial fibrillation: a brief review
Randhawa, S., Das, S., & Aronow, W. S. (2023) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2294728 · Cited by 5
Time–Frequency Analysis of Atrial Fibrillation
Sandberg, F., Stridh, M., & Sörnmo, L. (2008) · Synthesis lectures on biomedical engineering · doi:10.1007/978-3-031-01633-2_4 · Cited by 5
Long-Term Efficacy of Amiodarone Therapy for the Prevention of Recurrence of Paroxysmal Atrial Fibrillation Analysis Based on Patient Characteristics
Komatsu, T., Tachibana, H., Satō, Y., Ozawa, M., Kunugita, F., & Nakamura, M. (2011) · International Heart Journal · doi:10.1536/ihj.52.212 · Cited by 5
Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients: a propensity score matching analysis
Horio, T., Akiyama, M., Iwashima, Y., Yoshihara, F., Nakamura, S., Tokudome, T., Okutsu, M., Tanaka, H., Komatsubara, I., Okimoto, N., et al. (2016) · Journal of Human Hypertension · doi:10.1038/jhh.2016.95 · Cited by 5
Dual antithrombotic plus adjunctive antiinflammatory therapy to improve cardiovascular outcome in atrial fibrillation patients with concurrent acute coronary syndrome: A triple-pathway strategy
Chi, G., Jamil, A., Radulovic, M., Jamil, U., Balouch, M. A., Marszalek, J., Karimi, Z., Pahlavani, S., Jafarizade, M., Shaukat, H., et al. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.02.036 · Cited by 5
Renin Angiotenin Blocker Pre-treatment and Recurrence After Pulmonary Vein Isolation in Patients with Paroxysmal and Persistent Atrial Fibrillation.
Rosen, B. D., AKOUM, N. W., Burgon, N. S., Vergara, G., MARROUCHE, N. F., & Bader, F. M. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.898 · Cited by 5
First time and repeat cardioversion of atrial tachyarrhythmias - a comparison of outcomes
Arya, A., Silberbauer, J., Vrahimides, J., Cheek, E., Mitchell, A. R. J., Boodhoo, L. E., Pugh, P., Large, J., Bordoli, G., Taggu, W., et al. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02229.x · Cited by 5
Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation
Wachtell, K., Devereux, R. B., & Lyle, P. A. (2006) · Current Cardiology Reports · doi:10.1007/s11886-006-0075-1 · Cited by 5
Inhibition of the Renin-Angiotensin System and Atrial Fibrillation in Heart Failure
Palardy, M., & Ducharme, A. (2005) · Heart Drug · doi:10.1159/000089602 · Cited by 5

Authors: Ueng, K.
Affiliations: Chung Shan Medical University Hospital (TW)
Corresponding author: Ueng, K
ORCID: Ueng, K
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 2003-12
Volume: 24
Issue: 23
Pages: 2090-2098
ISSN: 0195-668X (ISSN-L)
DOI: 10.1016/j.ehj.2003.08.014
OpenAlex: W1946485105
Cited by: 293
References: 45
Citations by year: 2026: 2 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 6 · 2015: 7 · 2014: 6 · 2013: 13 · 2012: 9
FWCI: 13.45
Type: journal article
Language: en
Open access: closed
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: enalapril, amiodarone, atrial fibrillation, external cardioversion, sinus rhythm maintenance, atrial fibrillation recurrence, long-standing persistent atrial fibrillation, combination anticoagulant therapy, ACE inhibitors
MeSH terms: Adolescent, Adult, Aged, Amiodarone, Angiotensin-Converting Enzyme Inhibitors, Anti-Arrhythmia Agents, Antihypertensive Agents, Atrial Fibrillation, Combined Modality Therapy, Drug Therapy, Combination, Electric Countershock, Enalapril, Humans, Long-Term Care, Middle Aged, Prospective Studies, Treatment Outcome, Disease-Free Survival, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks